molecular medicine spa
(MLM:Borsa Italia MTA (Equities))
Earnings & Estimates Summary - MOLECULAR MEDICINE SPA (MLM)
2013 revenues at MolMed S.p.A. totaled €6.7M EUR, while annual losses equaled €0.08 per share.
Quarterly Earnings & Estimates - MOLECULAR MEDICINE SPA (MLM)
MolMed S.p.A.'s Quarterly Earnings
MolMed S.p.A. reported 1st quarter 2014 losses of €0.02 per share on 05/16/2014.
Annual Earnings & Estimates - MOLECULAR MEDICINE SPA (MLM)
MolMed S.p.A.'s Annual Earnings
MolMed S.p.A. reported annual 2013 losses of €0.08 per share on 03/5/2014.
Quarterly Revenues - MOLECULAR MEDICINE SPA (MLM)
MolMed S.p.A.'s Quarterly Revenues
MolMed S.p.A. had 1st quarter 2014 revenues of €1.4M EUR. This missed the €1.7M EUR estimate of the one analyst following the company. This was 9.7% above the prior year's 1st quarter results.
Annual Revenues - MOLECULAR MEDICINE SPA (MLM)
MolMed S.p.A.'s Annual Revenues
MolMed S.p.A. had revenues for the full year 2013 of €6.7M EUR. This was 32.7% above the prior year's results.
|No competitor information is available for MLM.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|